YIH
EGRX

Y-Intercept (HK)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Y-Intercept (HK)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,756
Closed -$248K – 1819
2023
Q1 		$248K Sell
8,756
-1,351
-13% -$38.3K 0.03% 860
2022
Q4 		$295K Buy
+10,107
New +$295K 0.04% 661